Authors
Latest:
Consent and ExperienceIn this month’s Legal Eagle column, we delve into cases involving informed consent.
Latest:
Same-Day TxSan Francisco - Two new dermal fillers approved for use without a pre-treatment skin test will enable dermatologists to offer patients same-day collagen replacement therapy.
Latest:
Experts Weigh in on Best Body-Focused Skin CareSlathering the body with the same skin-care products designed for the face is a bad idea, experts say.
Latest:
French Results Echo Expert FindingsAccording to a study in Annals of Dermatology and Venerology, pediatric patients with psoriasis in France frequently missed dermatologic consultations.
Latest:
Mouse Model May Shed Light on APC mutations in brain metastasesA grant from the Melanoma Research Foundation powers the initial stages of the project.
Latest:
Skin disease in tropical travelersNational report - Skin disease is one of the main reasons for consultation in travelers returning from the tropics, according to Eric Caumes, M.D., professor of infectious diseases and dermatologist in the department of infectious and tropical diseases at Hospital Piti?-Salp?tri?re in Paris.
Latest:
Hemangioma treatment side effects linked to low body weightBronchial hyperreactivity associated with propranolol treatment for infantile hemangiomas may be due to age and low body weight, study shows.
Latest:
Chemical lift with a phenol peelThe patient must be psychologically prepared for the clinical picture of the desquamation that results from the peel.
Latest:
Bail yourself out: Recover investment losses with tax benefitsThe current financial crisis has left many Americans with less wealth than they had just a year ago. Home and stock market investments are likely worth a lot less ? and it may be years until the values of these assets return to previous levels. Investment advisers Carole C. Foos, C.P.A., and David B. Mandell, J.D., M.B.A., offer a strategy with two simple steps to help you start now to make up for your losses.
Latest:
Onset acquires rights to acne med ClindagelThe acne medication Clindagel (clindamycin phosphate 1 percent) topical gel is now owned by Onset Dermatologics, according to a news release.
Latest:
Many with psoriasis go untreatedUp to 30 percent of patients with psoriasis do not seek medical care for their skin condition, patient surveys show.
Latest:
FDA approves injectable foam for varicose veinsThe Food and Drug Administration has approved Varithena (polidocanol injectable foam, BTG International) for the treatment of varicose veins.
Latest:
Isotretinoin: Time to reconsider blood test best practicesWhile oral isotretinoin has been associated with various side effects and routine blood tests have been recommended, evidence points to inconsistencies in monitoring practices. Many physicians also are questioning whether the effort has value.
Latest:
Efficacy of Hydrophobically-Modified Polymers and Green Cleansing TechnologiesAn expert in dermatology shares her thoughts on the role and efficacy of hydrophobically-modified polymers and green cleansing technologies comparing them to more traditional methods at AAD.
Latest:
Are you missing this business tool?Balancing a career or business, a family and a household is a given for many of us. When it comes to keeping cool and maintaining relationships with family, colleagues and our patients, communication and education are key. Here's how one tool can help.
Latest:
Antibiotic dialogue needs to continueI thoroughly enjoyed the lead article about “antimicrobial stewardship” in the October edition of Dermatology Times (“Antimicrobial stewardship: How dermatologists can be part of the solution, Vol. 34, No. 10). It succinctly and effectively detailed that for healthcare providers in general and dermatologists in specific, it is our duty to utilize antimicrobials appropriately.
Latest:
The Aesthetic Practice in 2021What will the aesthetic medicine look like in 2021? Dr. Suneel Chilukuri offers his perspective on how the pandemic will influence the practice in the New Year.
Latest:
Laser technology creates hi-res maps of acne lesionsAn exploration of the feasibility of using laser technology to detect changes in microvasculature during the acne lesion healing progress and to introduce a microvasculature-based biomarker in evaluating the treatment and grading of acne.
Latest:
Combination therapy improves survival in melanomaThe combination of encorafenib plus binimetinib significantly improved overall survival versus vemurafenib in patients with BRAF-mutant melanoma, updated results of the randomized, phase three COLUMBUS trial show.
Latest:
Skin of Color Seminar Series roundupA panel discussion on the increasing trend of total body skin lightening ― and ethical and health concerns associated with skin lightening ― was this year's most discussesd and controversial topic.
Latest:
Self-care Before Patient Care : 10 Ways to Boost Your Resilience in 2018 - Part 2In April we reviewed the first five tips to help boost your resilience and well being in 2018. Below are the final five in the second part of this two-part article.
Latest:
More new therapies under study for underarm sweatQbrexza was approved earlier this year for primary axillary hyperhidrosis. And, now, other treatments are under study. In his presentation at this week’s Fall Clinical Dermatology Conference in Las Vegas, Dr. David Pariser summarizes the latest research.
Latest:
8 Ways to improve Instagram resultsMarketing expert Justin Knott explains how to grow your Instagram following as part of a successful digital practice marketing strategy.
Latest:
The journey begins when the trip endsWE medical trip to India ends in eye-opening lessons learned.
Latest:
Technology: A private practice’s best friendPennsylvania Dermatology Partners tells its story of technological support and success.
Latest:
Life-threatening emergency cases in dermatologyLife-threatening emergency cases may be rare, but they can be complex. At EADV this week, experts review cases physicians should be aware of.
Latest:
A review of treatment for dermatofibrosarcomaDermatofibrosarcoma is a common, but unusual locally aggressive cutaneous tumor. Its characteristic tentacle can grow into surrounding fat, muscle and even bone. For dermatologists this means that understanding treatment options is a priority, says a physician reporting from EADV 2018.
Latest:
Nuogen Pharma: Innovation in the fight against itchNuogen Pharma’s mission is to deliver the first FDA-approved anti-itch medication for chronic pruritus of unknown origin (CPUO) and other chronic itch conditions.
Latest:
Continuing the innovation journeyIn recognition of the first anniversary of our Innovation column, Drs. Steve Xu and William Ju reflect on the range of topics covered throughout the year and highlight what's to come.
Latest:
Good skin health and a diverse microbiome go hand-in-handCosmetic products with prebiotics, probiotics and postbiotics may be beneficial in treating eczema, a physician reported at the Fall Clinical Dermatology Conference held earlier this month in Las Vegas.
